FDA Webview Site FDA Review Site FDA Updater Site
header.gif
Username:
Password:
 

human drugs
animal drugs
biologics
eirs 483s
medical devices
marketing
email
search our site
  
FDA-RELATED NEWS
 
 
 
TXT Congressman Quizzes FDA on 510(k) Safety, Morcellators [357 Words]
02/20/2015
 
 
TXT Morcellator Cancer Rate 10 Times FDA’s Number: Study [262 Words]
02/19/2015
 
 
TXT Ex-FDAer Waxler to Oppose Avedro NDA at Advisory Cte. [304 Words]
02/18/2015
 
 
TXT FDA Allows 23andMe Genetic Carrier Test on the Market [550 Words]
02/20/2015
 
 
TXT Potential FDA Chief Has Industry Ties: Time [702 Words]
02/19/2015
 
 
TXT UDI Implementation Has Had Problems: AdvaMed’s Trunzo [255 Words]
02/19/2015
 
 
TXT Courts Mixed on Protection for Compliance Documents [419 Words]
02/18/2015
 
 
TXT Prosecutors See Unaddressed Medical Device Misconduct [471 Words]
02/17/2015
 
 
TXT Product Approval Summaries [502 Words]
02/22/2015
 
 
TXT Since Our Last Issue ... [441 Words]
02/22/2015
 
 
TXT Latest Federal Register Notices [1502 Words]
02/22/2015
 
 
TXT BIO Critiques Pediatric Priority Review Vouchers [345 Words]
02/20/2015
 
 
TXT FDA Denies Generic Janumet Petition [249 Words]
02/19/2015
 
 
TXT Courts Should Stop ‘Vicarious Liability’ Claims: Attorney [410 Words]
02/19/2015
 
 
TXT ANDA Applicants Question FDA on Data Sharing [366 Words]
02/19/2015
 
 
TXT Reprocessing Duodenoscopes Can Cause Problems: FDA [286 Words]
02/19/2015
 
 
TXT CBER Draft Guidance on Cell/Tissue Adverse Event Reporting [746 Words]
02/19/2015
 
 
TXT New Patent Law ‘Won’t Spur Drug Exclusivity Forfeiture’ [520 Words]
02/18/2015
 
 
TXT CDER Appoints Jarow to Medical Policy Acting Director [212 Words]
02/18/2015
 
 
TXT Multiple QS Violations at Verichem [449 Words]
02/17/2015
 
 
TXT Europe Struggles with Drug Promotion Violations: Study [288 Words]
02/17/2015
 
 
TXT Latest FDA Warning Letters [551 Words]
02/17/2015
 
 
TXT HHS Releases Draft e-Health Records Roadmap [285 Words]
02/17/2015
 
 
TXT Abiomed Securities Case May Affect Other Fraud: Attorney [381 Words]
02/17/2015
 
 
TXT FDA Sets ‘Listening’ Meeting on Changes Being Effected [364 Words]
02/17/2015
 
 
 
 
The most authoritative FDA news analysis each week is found in the pages of Dickinson's FDA Review. Since 1984, this newsletter has been providing in-depth reports on the most significant FDA developments affecting the pharmaceutical, medical device, biologics and veterinary medicines industries. Unlike other media, FDA Review eliminates time-wasting minutia and presents in clear, concise language the essence of what's really important - and why. It is the publication that FDA officials themselves read. Delivered in the middle of each week, FDA Review presents:
  • The latest agency policy developments, often before they're officially announced;
  • Major news insights, follow-ups and reactions in each product area;
  • Summaries of the latest Warning Letters;
  • The newest product approvals;
  • Summaries of the latest FDA Federal Register notices;
  • Summaries of DDMAC letters;
  • Related industry news capsules;
  • The industry's most concise FDA news index;
  • Inside-FDA news briefs
You can rely on FDA Review to provide only what's important - in the most convenient and time-saving